TRICARE; Coverage of National Cancer Institute (NCI) Sponsored Phase I Studies
personnel · US Department of Defense · Rule · Published 2011-01-13 · Effective 2011-02-14 · 76 FR 2253
Document
Document number
2011-621
Federal Register citation
76 FR 2253
CFR reference
32 CFR 199
Type
Rule
Action
Final rule.
Category
personnel
Sub-agency
US Department of Defense
Publication date
2011-01-13
Effective date
2011-02-14
DOD docket
DoD-2009-HA-0051
Abstract
This final rule adds coverage of National Cancer Institute (NCI) sponsored Phase I studies for certain beneficiaries. The NCI sponsored clinical treatment trials are conducted in a series of steps called phases. Phase I trials are the first studies conducted in people. They evaluate how a new drug should be given (by mouth, injected into the blood, or injected into the muscle), how often, and what dose is safe.